| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |